Ganser A - Search Results

1

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.

Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich H, Rühl H, et al. Hoelzer D, et al. Among authors: ganser a. Blood. 1988 Jan;71(1):123-31. Blood. 1988. PMID: 3422030 Free article.

2

Interleukin-3 and granulocyte-macrophage colony-stimulating factor in combination: clinical implication.

Frisch J, Ganser A, Hoelzer D, Brugger W, Kanz L, Mertelsmann R, Schulz G. Frisch J, et al. Among authors: ganser a. Med Pediatr Oncol Suppl. 1992;2:34-7. doi: 10.1002/mpo.2950200709. Med Pediatr Oncol Suppl. 1992. PMID: 1306886 Clinical Trial.

3

Treatment of myelodysplastic syndromes with cytokines and cytotoxic drugs.

Ganser A, Seipelt G, Eder M, Geissler G, Ottmann OG, Hess U, Hoelzer D. Ganser A, et al. Semin Oncol. 1992 Apr;19(2 Suppl 4):95-101. Semin Oncol. 1992. PMID: 1372766 Review.

4

Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses.

Schardt C, Ottmann OG, Hoelzer D, Ganser A. Schardt C, et al. Among authors: ganser a. Leukemia. 1992 May;6(5):370-4. Leukemia. 1992. PMID: 1375695

5

Treatment of myelodysplastic syndromes with hematopoietic growth factors.

Ganser A, Hoelzer D. Ganser A, et al. Hematol Oncol Clin North Am. 1992 Jun;6(3):633-53. Hematol Oncol Clin North Am. 1992. PMID: 1377194 Review.

6

Lack of c-kit proto-oncogene rearrangement in patients with acute lymphoblastic leukemia (ALL) and the t(4;11)(q21;q23) translocation.

Schardt C, Stadler M, Hoelzer D, Ganser A. Schardt C, et al. Among authors: ganser a. Leukemia. 1992 Oct;6(10):1079-80. Leukemia. 1992. PMID: 1383648 No abstract available.

7

Interleukin-3 in the treatment of myelodysplastic syndromes.

Ganser A, Ottmann OG, Hoelzer D. Ganser A, et al. Int J Clin Lab Res. 1992;22(3):125-8. doi: 10.1007/BF02591411. Int J Clin Lab Res. 1992. PMID: 1520908 Review.

8

Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).

Hess U, Ganser A, Schnürch HG, Seipelt G, Ottmann OG, Falk S, Schulz G, Hoelzer D. Hess U, et al. Among authors: ganser a. Br J Haematol. 1992 Feb;80(2):254-6. doi: 10.1111/j.1365-2141.1992.tb08910.x. Br J Haematol. 1992. PMID: 1550786 No abstract available.

9

Presence of more than two rearranged immunoglobulin heavy-chain genes in adult precursor B-cell acute lymphoblastic leukemia.

Schardt C, Hoelzer D, Ganser A. Schardt C, et al. Among authors: ganser a. Ann Hematol. 1992 Feb;64(2):72-7. doi: 10.1007/BF01715348. Ann Hematol. 1992. PMID: 1554798

10

Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study.

Ganser A, Lindemann A, Ottmann OG, Seipelt G, Hess U, Geissler G, Kanz L, Frisch J, Schulz G, Herrmann F, et al. Ganser A, et al. Blood. 1992 May 15;79(10):2583-91. Blood. 1992. PMID: 1586711 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

886 results

Search Page

Filters